-
Electronic (PDF)
-
Site License
-
Enterprisewide
Malaysia Healthcare Industry 2H11
Emerging Markets Direct, May 2012, Pages: 32
Malaysia: Healthcare covers the country's healthcare industry overview in terms of healthcare services, health human resources, healthcare expenditure and private market size. It also covers health tourism and health insurance, as well as the growth opportunities and market trends, industry SWOT, healthcare incentives and healthcare reforms, plus the comparative matrix and SWOT analysis of the leading players: KPJ Healthcare Berhad (KPJ), TMC Life Sciences Berhad (TMCL) and Faber Group Berhad (FGB).
Under the 10th Malaysia Plan (2011–2015), the government has identified healthcare services as one of the 12 National Key Economic Areas (NKEA) to generate revenue for the country. Malaysia now has 8 Joint Commission International (JCI) and 24 Malaysia Society for Quality in Health (MSQH) accredited hospitals, with another 31 hospitals and ambulatory care facilities in the process of becoming accredited.
Market drivers such as rising middle and affluent income population, medical tourism, rise in chronic disease and aging and growing population will impact the healthcare services market, according to Frost & Sullivan. Conversely, market constrains such as medical personnel shortage, discrepancy between urban and rural regions and the inability to meet the demand of healthcare services in towns and rural areas will set the market back.
According to the World Bank health statistics, Malaysia’s spending on healthcare was estimated at 4.4% of its GDP in 2011. Currently, government expenditure accounts 54.4% of the total expenditure. Private sector services mainly dominate the healthcare industry in Malaysia. Frost & Sullivan estimated the private healthcare sector to generate revenue of MYR 13.8bn in 2015 as compared to MYR 7.5bn in 2011, growing at a CAGR of 16.5% during 2010–2020.
Besides, Malaysia is fast becoming the destination of choice for medical tourists behind Thailand and Singapore, driven by affordable costs, specialised hospitals, high-quality medical care and short waiting times. According to the Malaysian Healthcare Travel Council (MHTC), the number of foreign patients seeking medical treatment in Malaysia surged by 47.2% y/y to 578,403 in 2011, generating revenue of MYR 509.8mn, up 34.5% y/y.
KPJ Healthcare Berhad is the largest private healthcare operator in the country with more than 2,700 beds across its hospitals or about 21% of the total private sector capacity. The group also has the highest share of patient admissions and the largest number of medical personnel.
1. Industry profile
1.1 Asia-Pacific overview
1.1.1 Healthcare market
1.1.2 Pharmaceutical market
1.2 Malaysia overview
1.2.1 Healthcare services
1.2.2 Health human resources
1.2.3 Healthcare expenditure
1.2.4 Private sector market size
1.3 Health tourism
1.3.1 Size and value
1.3.2 Treatment costs
1.3.3 Accreditations
1.4 Health insurance
2. Market trends and outlook
2.1 Growth opportunities and market trends
2.2 Industry SWOT
2.3 Healthcare incentives
2.4 Healthcare reforms
3. Leading players and comparative matrix
3.1 Leading players
3.1.1 KPJ Healthcare Berhad
3.1.2 TMC Life Sciences Berhad
3.1.3 Faber Group Berhad
3.2 Comparative matrix
3.3 SWOT analysis
4. Tables and charts
Table 1: Major trends impacting healthcare market opportunities
Table 2: Admissions and outpatient attendances in 2010
Table 3: Public sector healthcare facilities in 2010
Table 4: Private sector healthcare facilities in 2010
Table 5: Medical personnel ratio to population in 2010
Table 6: Cost comparison of selected medical procedures (in USD)
Table 7: Cost of public hospital treatment for foreign patients
Table 8: JCI accredited medical providers in Malaysia
Table 9: KPJ hospital expansion plans
Table 10: KPJ five-year financial highlights
Table 11: TMC five-year financial highlights
Table 12: FGB five-year financial highlights
Table 13: Selected peer comparison of key financial ratios
Chart 1: Global pharmaceutical market by region in 2010
Chart 2: Healthcare industry expenditure in 2011
Chart 3: Total health expenditure as % of GDP (2001–2011)
Chart 4: Health expenditure per capita (2001–2010)
Chart 5: Private hospitals domestic market share by beds
Chart 6: ASEAN medical tourism market share in 2010
Chart 7: Growth of health tourists and receipts (2004–2012)
Chart 8: Malaysian health tourists by nationality (%)
Chart 9: KPJ revenue breakdown in 2011
Chart 10: FGB revenue contribution by country
Product Samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
